A sustained-release formulation of a local anesthetic using our SABER® Delivery System for the treatment of post surgical pain.
View complete product pipeline
June 29, 2015DURECT to Present at the Cantor Fitzgerald Healthcare Conference
June 23, 2015DURECT Announces Plans for a New POSIDUR™ (SABER®-Bupivacaine) Clinical Trial
May 18, 2015DURECT Announces Positive Results from DUR-928 Multi-Dose Phase 1 Study
April 30, 2015DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs